» Articles » PMID: 32713710

Neuropsychiatric Symptoms in an Adolescent Boy With Multisystem Inflammatory Syndrome in Children

Overview
Journal Psychosomatics
Publisher Elsevier
Specialty Psychiatry
Date 2020 Jul 28
PMID 32713710
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Elevated risk for psychiatric outcomes in pediatric patients with Multisystem Inflammatory Syndrome (MIS-C): A review of neuroinflammatory and psychosocial stressors.

Pan T, Gallo M, Donald K, Webb K, Bath K Brain Behav Immun Health. 2024; 38():100760.

PMID: 38586284 PMC: 10992702. DOI: 10.1016/j.bbih.2024.100760.


Neurological manifestations of Kawasaki disease and multisystem inflammatory syndrome in children associated with COVID-19: A comparison of two different clinical entities.

Mauro A, Di Mari C, Casini F, Giani T, Sandini M, Biondi L Front Pediatr. 2023; 10:1088773.

PMID: 36683824 PMC: 9849814. DOI: 10.3389/fped.2022.1088773.


Severe Agitation as an Unusual Presentation of Multisystem Inflammatory Syndrome in Children.

Ghamry M, Salib K, Henin S, Salah R, Dobs M Cureus. 2022; 14(8):e27621.

PMID: 36059320 PMC: 9436482. DOI: 10.7759/cureus.27621.


New-Onset Mania and Psychosis in Adolescents in the Context of COVID-19 Infection.

Meeder R, Adhikari S, Sierra-Cintron K, Aedma K Cureus. 2022; 14(4):e24322.

PMID: 35607548 PMC: 9123385. DOI: 10.7759/cureus.24322.


Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review.

Lacinel Gurlevik S, Gunbey C, Ozsurekci Y, Oygar P, Kesici S, Gocmen R Eur J Paediatr Neurol. 2022; 37:139-154.

PMID: 35287009 PMC: 8853984. DOI: 10.1016/j.ejpn.2022.02.003.


References
1.
Gust J, Taraseviciute A, Turtle C . Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies. CNS Drugs. 2018; 32(12):1091-1101. PMC: 7295115. DOI: 10.1007/s40263-018-0582-9. View

2.
Dietz S, van Stijn D, Burgner D, Levin M, Kuipers I, Hutten B . Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr. 2017; 176(8):995-1009. PMC: 5511310. DOI: 10.1007/s00431-017-2937-5. View

3.
McNeil J, Hughes C, Girard T, Ware L, Wesley Ely E, Chandrasekhar R . Plasma biomarkers of inflammation, coagulation, and brain injury as predictors of delirium duration in older hospitalized patients. PLoS One. 2019; 14(12):e0226412. PMC: 6922408. DOI: 10.1371/journal.pone.0226412. View

4.
Takanashi J, Shirai K, Sugawara Y, Okamoto Y, Obonai T, Terada H . Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci. 2011; 315(1-2):167-9. DOI: 10.1016/j.jns.2011.11.022. View

5.
Tabarki B, Mahdhaoui A, Selmi H, Yacoub M, Essoussi A . Kawasaki disease with predominant central nervous system involvement. Pediatr Neurol. 2001; 25(3):239-41. DOI: 10.1016/s0887-8994(01)00290-9. View